Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
13667 | 758 | 32.2 | 82% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | NEUTROPHIL TO LYMPHOCYTE RATIO | Author keyword | 14 | 25% | 7% | 50 |
2 | LEUKOCYTE COUNT | Author keyword | 11 | 25% | 5% | 40 |
3 | WHITE BLOOD CELL COUNT | Author keyword | 11 | 20% | 6% | 49 |
4 | NEUTROPHIL LYMPHOCYTE RATIO | Author keyword | 10 | 22% | 5% | 39 |
5 | ALBERT E EIN PREVENT MED | Address | 4 | 67% | 1% | 4 |
6 | WHITE BLOOD CELL | Author keyword | 4 | 14% | 3% | 26 |
7 | INFARCT RELATED ARTERY PATENCY | Author keyword | 3 | 50% | 1% | 4 |
8 | ENSINO PESQUISA ISRAELITA | Address | 3 | 60% | 0% | 3 |
9 | PLATELET TO LYMPHOCYTE RATIO | Author keyword | 3 | 25% | 1% | 9 |
10 | ELIACHAR | Address | 2 | 24% | 1% | 9 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LEUKOCYTE COUNT | 60 | 31% | 21% | 158 |
2 | BLOOD CELL COUNT | 44 | 22% | 23% | 175 |
3 | NEUTROPHIL LYMPHOCYTE RATIO | 16 | 26% | 7% | 53 |
4 | ELEVATED NEUTROPHIL | 16 | 53% | 3% | 21 |
5 | BLOOD CELL SUBTYPES | 11 | 69% | 1% | 9 |
6 | DIFFERENTIAL LEUKOCYTE COUNTS | 10 | 52% | 2% | 14 |
7 | ELEVATED LEUKOCYTE COUNT | 9 | 83% | 1% | 5 |
8 | MALE OFFICE WORKERS | 6 | 48% | 1% | 10 |
9 | CLUSTERED COMPONENTS | 6 | 80% | 1% | 4 |
10 | LYMPHOCYTE CONCENTRATION | 4 | 75% | 0% | 3 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Neutrophils and clinical outcomes in patients with acute coronary syndromes and/or cardiac revascularisation A systematic review on more than 34,000 subjects | 2011 | 40 | 44 | 55% |
Leukocyte count and coronary heart disease - Implications for risk assessment | 2004 | 241 | 96 | 44% |
Neutrophil to lymphocyte ratio in relation to risk of all-cause mortality and cardiovascular events among patients undergoing angiography or cardiac revascularization: A meta-analysis of observational studies | 2014 | 6 | 28 | 61% |
Components of the Complete Blood Count as Risk Predictors for Coronary Heart Disease In-Depth Review and Update | 2013 | 21 | 149 | 40% |
Predictive value of elevated neutrophil-lymphocyte ratio on cardiac mortality in patients with stable coronary artery disease | 2008 | 101 | 33 | 36% |
Leukocytosis as a predictor for non-infective mortality and morbidity | 2010 | 12 | 40 | 78% |
Role of polymorphonuclear neutrophils in atherosclerosis: Current state and future perspectives | 2010 | 67 | 101 | 19% |
Leukocytosis and ischemic vascular disease morbidity and mortality - Is it time to intervene? | 2005 | 145 | 108 | 22% |
Low Lymphocyte Count and Cardiovascular Diseases | 2011 | 9 | 71 | 41% |
Prognostic value of leukocytosis in acute coronary syndromes: The cinderella of the inflammatory markers | 2006 | 15 | 63 | 43% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ALBERT E EIN PREVENT MED | 4 | 67% | 0.5% | 4 |
2 | ENSINO PESQUISA ISRAELITA | 3 | 60% | 0.4% | 3 |
3 | ELIACHAR | 2 | 24% | 1.2% | 9 |
4 | CHAIM SHEBA MED MANAGEMENT | 1 | 50% | 0.3% | 2 |
5 | EVLIYA CELEBI EDUC HOSP | 1 | 50% | 0.3% | 2 |
6 | IRCCS RECOVERY CARE SCI CHARACTER | 1 | 100% | 0.3% | 2 |
7 | AREA FISIOL UMANA | 1 | 50% | 0.1% | 1 |
8 | CARDIOVASC HOSP CLIN | 1 | 50% | 0.1% | 1 |
9 | COMPUTERIZAT METHODOL CONSULTANCY | 1 | 50% | 0.1% | 1 |
10 | CORSO LAUREA SCI MOTORIE METODI VALUTAZ ATTITUD | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000118414 | C REACTIVE PROTEIN//HIGH SENSITIVITY C REACTIVE PROTEIN//CARDIOVASC DIS PREVENT |
2 | 0.0000118020 | HMC05//HEBEI PROV PEOPLES HOSP//DIPARTIMENTO CHIRURG GEN PARIDE STEFANINI |
3 | 0.0000098830 | GLASGOW PROGNOSTIC SCORE//NEUTROPHIL TO LYMPHOCYTE RATIO//NEUTROPHIL LYMPHOCYTE RATIO |
4 | 0.0000085424 | LEUKOCYTE ADHESIVENESS AGGREGATION//LEUKOCYTE ADHESIVENESS//LEUKOCYTE AGGREGATION |
5 | 0.0000082989 | MEAN PLATELET VOLUME//PLATELET DISTRIBUTION WIDTH//PLATELET INDICES |
6 | 0.0000061346 | MONOCYTE SUBSETS//MONOCYTE HETEROGENEITY//MONOCYTE SUBSET |
7 | 0.0000059474 | CORONARY ARTERIAL TONE//VASC BIOL MED ERFURT//PLATELET NEUTROPHIL INTERACTION |
8 | 0.0000058240 | FIBRINOGEN//BLOOD VISCOSITY//PLASMA VISCOSITY |
9 | 0.0000056767 | VASCULAR DENDRITIC CELLS//MOL MED CEMM//OPPENHEIMER ATHEROSCLEROSIS |
10 | 0.0000055550 | RED CELL DISTRIBUTION WIDTH//RED BLOOD CELL DISTRIBUTION WIDTH//RDW |